Hosted on MSN
Dr. Reddy’s Lab launches India’s first DCGI-approved semaglutide injection for type 2 diabetes
Dr. Reddy’s Laboratories on Saturday launched Obeda, a semaglutide injection for Type 2 diabetes, becoming the first Indian company to receive approval from the Drugs Controller General of India (DCGI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results